In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells (2024)

  • Hamatani, T., Carter, M. G., Sharov, A. A. & Ko, M. S. Dynamics of global gene expression changes during mouse preimplantation development. Dev. Cell 6, 117–131 (2004).

    Article CAS Google Scholar

  • Lyon, M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372–373 (1961).

    Article CAS Google Scholar

  • Gu, T. P. et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606–610 (2011).

    Article CAS Google Scholar

  • Guo, F. et al. Active and passive demethylation of male and female pronuclear DNA in the mammalian zygote. Cell Stem Cell 15, 447–459 (2014).

    Article CAS Google Scholar

  • Rougier, N. et al. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 12, 2108–2113 (1998).

    Article CAS Google Scholar

  • Bedzhov, I., Graham, S. J., Leung, C. Y. & Zernicka-Goetz, M. Developmental plasticity, cell fate specification and morphogenesis in the early mouse embryo. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20130538 (2014).

  • Saiz, N. & Plusa, B. Early cell fate decisions in the mouse embryo. Reproduction 145, R65–R80 (2013).

    Article CAS Google Scholar

  • Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).

    Article CAS Google Scholar

  • Kunath, T. et al. Imprinted X-inactivation in extra-embryonic endoderm cell lines from mouse blastocysts. Development 132, 1649–1661 (2005).

    Article CAS Google Scholar

  • Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634–7638 (1981).

    Article CAS Google Scholar

  • Tanaka, S., Kunath, T., Hadjantonakis, A. K., Nagy, A. & Rossant, J. Promotion of trophoblast stem cell proliferation by FGF4. Science 282, 2072–2075 (1998).

    Article CAS Google Scholar

  • Macfarlan, T. S. et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature 487, 57–63 (2012).

    Article CAS Google Scholar

  • Choi, Y. J. et al. Deficiency of microRNA miR-34a expands cell fate potential in pluripotent stem cells. Science 355, eaag1927 (2017).

    Article Google Scholar

  • Morgani, S. M. et al. Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep. 3, 1945–1957 (2013).

    Article CAS Google Scholar

  • Yang, J. et al. Establishment of mouse expanded potential stem cells. Nature 550, 393–397 (2017).

    Article CAS Google Scholar

  • Tarkowski, A. K. & Wroblewska, J. Development of blastomeres of mouse eggs isolated at the 4- and 8-cell stage. J. Embryol. Exp. Morphol. 18, 155–180 (1967).

    CAS PubMed Google Scholar

  • Yamanaka, Y., Ralston, A., Stephenson, R. O. & Rossant, J. Cell and molecular regulation of the mouse blastocyst. Dev. Dyn. 235, 2301–2314 (2006).

    Article CAS Google Scholar

  • Johnson, M. H. & Ziomek, C. A. The foundation of two distinct cell lineages within the mouse morula. Cell 24, 71–80 (1981).

    Article CAS Google Scholar

  • Yagi, R. et al. Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 134, 3827–3836 (2007).

    Article CAS Google Scholar

  • Nishioka, N. et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16, 398–410 (2009).

    Article CAS Google Scholar

  • Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol. Rev. 94, 1287–1312 (2014).

    Article CAS Google Scholar

  • Azzolin, L. et al. YAP/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response. Cell 158, 157–170 (2014).

    Article CAS Google Scholar

  • Sonderegger, S., Pollheimer, J. & Knofler, M. Wnt signalling in implantation, decidualisation and placental differentiation--review. Placenta 31, 839–847 (2010).

    Article CAS Google Scholar

  • Chan, S. W. et al. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J. Biol. Chem. 286, 7018–7026 (2011).

    Article CAS Google Scholar

  • Wang, W., Huang, J. & Chen, J. Angiomotin-like proteins associate with and negatively regulate YAP1. J. Biol. Chem. 286, 4364–4370 (2011).

    Article CAS Google Scholar

  • Zhao, B. et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 25, 51–63 (2011).

    Article Google Scholar

  • Wang, W. et al. Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins. Cell Rep. 13, 524–532 (2015).

    Article Google Scholar

  • Lu, C. W. et al. Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos. Nat. Genet. 40, 921–926 (2008).

    Article CAS Google Scholar

  • Maekawa, M. et al. Requirement of the MAP kinase signaling pathways for mouse preimplantation development. Development 132, 1773–1783 (2005).

    Article CAS Google Scholar

  • Li, X. et al. Calcineurin-NFAT signaling critically regulates early lineage specification in mouse embryonic stem cells and embryos. Cell Stem Cell 8, 46–58 (2011).

    Article CAS Google Scholar

  • Kapoor, A. et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell 158, 185–197 (2014).

    Article CAS Google Scholar

  • Shao, D. D. et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158, 171–184 (2014).

    Article CAS Google Scholar

  • Wilson, M. B., Schreiner, S. J., Choi, H. J., Kamens, J. & Smithgall, T. E. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Oncogene 21, 8075–8088 (2002).

    Article CAS Google Scholar

  • Martello, G. et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 11, 491–504 (2012).

    Article CAS Google Scholar

  • Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008).

    Article CAS Google Scholar

  • Zimmerlin, L. et al. Tankyrase inhibition promotes a stable human naive pluripotent state with improved functionality. Development 143, 4368–4380 (2016).

    Article CAS Google Scholar

  • Kim, H. et al. Modulation of beta-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat. Commun. 4, 2403 (2013).

    Article Google Scholar

  • Ryan, D. J., Yang, J., Lan, G. & Liu, P. Derivation and maintenance of mouse expanded potential stem cells. Protoc. Exch. https://doi.org/10.1038/protex.2017.102 (2017).

  • Baker, C. L. & Pera, M. F. Capturing totipotent stem cells. Cell Stem Cell 22, 25–34 (2018).

    Article CAS Google Scholar

  • Niakan, K. K., Schrode, N., Cho, L. T. & Hadjantonakis, A. K. Derivation of extraembryonic endoderm stem (XEN) cells from mouse embryos and embryonic stem cells. Nat. Protoc. 8, 1028–1041 (2013).

    Article CAS Google Scholar

  • Matsunari, H. et al. Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs. Proc. Natl. Acad. Sci. USA 110, 4557–4562 (2013).

    Article CAS Google Scholar

  • Yang, Y. et al. Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency. Cell 169, 243–257.e25 (2017).

    Article CAS Google Scholar

  • Hemberger, M. et al. Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev. Biol. 257, 371–381 (2003).

    Article CAS Google Scholar

  • Yang, J. et al. Signalling through retinoic acid receptors is required for reprogramming of both mouse embryonic fibroblast cells and epiblast stem cells to induced pluripotent stem cells. Stem Cells 33, 1390–1404 (2015).

    Article CAS Google Scholar

  • Hung, S. S. et al. Repression of global protein synthesis by Eif1a-like genes that are expressed specifically in the two-cell embryos and the transient Zscan4-positive state of embryonic stem cells. DNA Res. 20, 391–402 (2013).

    Article CAS Google Scholar

  • Sasaki, H., Ferguson-Smith, A. C., Shum, A. S., Barton, S. C. & Surani, M. A. Temporal and spatial regulation of H19 imprinting in normal and uniparental mouse embryos. Development 121, 4195–4202 (1995).

    CAS PubMed Google Scholar

  • Thomas, K. R. & Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503–512 (1987).

    Article CAS Google Scholar

  • McMahon, A. P. & Bradley, A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1073–1085 (1990).

    Article CAS Google Scholar

  • In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells (2024)

    FAQs

    What are the advantages of using mouse embryonic stem cells? ›

    First, they are at present the only stem cells that can be readily isolated and grown in culture in sufficient abundance to be useful. Secondly—at least for mice—they can be used to generate a normal animal, which indicates that they are unaltered and potentially safe for therapeutic use.

    Are embryonic stem cells in vitro? ›

    Most embryonic stem cells are developed from eggs that have been fertilized in an in vitro clinic, not from eggs fertilized in vivo. Somatic or adult stem cells are undifferentiated and found among differentiated cells in the whole body after development.

    What is the embryonic stem cell method in mice? ›

    Mouse embryonic stem cells (mESCs) were first isolated and propagated in culture in 1981. mESCs are typically isolated from blastocysts from the inner cell mass of 3.5-day-old embryos and have the potential to generate every cell type found in the body.

    Are embryonic stem cells pluripotent or totipotent? ›

    Embryonic stem cells (ESCs) are isolated from preimplantation embryos and can contribute to all tissues of the embryo, but not extraembryonic tissues (e.g., placenta). Therefore, they are considered pluripotent, not totipotent.

    Why are embryonic stem cells preferred? ›

    Embryonic stem cells are the most versatile since they can develop into all the cells of the developing fetus. The majority of stem cells in the body have fewer abilities to give rise to cells and may only help maintain and repair the tissues and organs in which they reside.

    What is the disadvantage of using embryonic stem cells? ›

    Opponents argue that the research is unethical, because deriving the stem cells destroys the blastocyst, an unimplanted human embryo at the sixth to eighth day of development.

    What are the characteristics of a mouse embryonic stem cell? ›

    Mouse ES cells display unusual proliferative properties. Their derivation does not rely on any immortalizing agent, they cannot enter a quiescence state, they do not undergo senescence, and they can proliferate without apparent limit.

    Why are mouse embryos used? ›

    In addition to limb studies, surgeries on rodent embryos have been used to study a wide range of developing tissues and organs including the nervous system, musculoskeletal system, digestive system, hematopoietic system, reproductive system, and, as well, the wound healing response that transitions from scarless ...

    Why did they use embryonic stem cells? ›

    Embryonic stem cells have huge potential in the field of tissue engineering and regenerative medicine as they hold the capacity to produce every type of cell and tissue in the body.

    What is the difference between stem cells and pluripotent stem cells? ›

    Pluripotent stem cells have the ability to differentiate into all of the cells of the adult body. Adult stem cells are found in a tissue or organ and can differentiate to yield the specialized cell types of that tissue or organ.

    What are embryonic and pluripotent stem cells? ›

    Scientists use the label 'embryonic stem cell', or ES cell, as a general term for pluripotent stem cells made from very early (pre-implantation stage) embryos. Conventional ES cells are derived from embryos produced by in vitro fertilization (IVF), a common type of infertility treatment.

    Can pluripotent stem cells become embryonic stem cells? ›

    Embryonic stem cells come from pluripotent cells, which exist only at the earliest stages of embryonic development. In humans, these cells no longer exist after about five days of development. When isolated from the embryo and grown in a lab dish, pluripotent cells can continue dividing indefinitely.

    What are the advantages of the mouse model organism? ›

    Mice have many advantages over other model organisms: Their genome is similar to the human genome (99%), a good genetic/molecular toolbox is available and the animal's small size facilitates large scale/high throughput studies making it a cost-efficient model.

    Which of the following is an advantage of using embryonic stem cells? ›

    Embryonic stem cells are able to differentiate into a wider range of cells than adult stem cells. Explanation: Embryonic stem cells has the capability to make any cell in the body because of pluripotent.

    What are the benefits of genetically modified mice? ›

    They have been used to study and model obesity, heart disease, diabetes, arthritis, substance abuse, anxiety, aging, temperature and pain reception, and Parkinson disease. Transgenic mice generated to carry cloned oncogenes and knockout mice lacking tumor suppressing genes have provided good models for human cancer.

    Why are mice used in stem cell research? ›

    Mice have been a species of choice to study stem cell biology in mammals. They are relatively inexpensive, reproduce quickly, and can be easily manipulated genetically.

    Top Articles
    Latest Posts
    Article information

    Author: Lidia Grady

    Last Updated:

    Views: 5435

    Rating: 4.4 / 5 (65 voted)

    Reviews: 88% of readers found this page helpful

    Author information

    Name: Lidia Grady

    Birthday: 1992-01-22

    Address: Suite 493 356 Dale Fall, New Wanda, RI 52485

    Phone: +29914464387516

    Job: Customer Engineer

    Hobby: Cryptography, Writing, Dowsing, Stand-up comedy, Calligraphy, Web surfing, Ghost hunting

    Introduction: My name is Lidia Grady, I am a thankful, fine, glamorous, lucky, lively, pleasant, shiny person who loves writing and wants to share my knowledge and understanding with you.